Clinical Trial Update: Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial comparing rituximab alone to rituximab plus intravenous cyclophosphamide in severe pemphigus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)

Snippet

Sponsor: Uprety Shraddha | Conditions: Pemphigus | Phase 3 | Status: UNKNOWN